Don’t let the high cost of brand HIV antiretrovirals disrupt your treatment. We help eligible patients access Emtriva (emtricitabine) for as little as $69.95 per month through the manufacturer’s Patient Assistance Program.
The Emtriva Prescription Assistance Program is a manufacturer-sponsored initiative that provides Emtriva at little or no medication cost to qualifying patients based on income and insurance status. The program is designed for HIV treatment patients who are uninsured or underinsured, as well as Medicare Part D beneficiaries.
Navigating the program on your own means dealing with eligibility verification, HIV provider coordination, prior-authorization documentation, and renewal deadlines.
AffordMyPrescriptions eliminates that burden. For a flat $69.95 per month, our Patient Advocates handle every step of your enrollment, from initial application through ongoing refill coordination and annual re-certification.
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Walgreens (brand) | ~$880.00 | Save ~$810/mo |
| CVS Pharmacy (brand) | ~$900.00 | Save ~$830/mo |
| Walmart (brand) | ~$750.00 | Save ~$680/mo |
| Costco (brand) | ~$720.00 | Save ~$650/mo |
| Generic emtricitabine | ~$30.00 | Already low |
*Just a heads-up — retail prices are estimates based on public data and vary by pharmacy. AffordMyPrescriptions Advocacy Service bypasses this by using drug manufacturer programs to secure your medication directly at no cost or retail price.
1 Medications
2 Medications
3 Medications
4+ Medications
The Patient Assistance Program is free to apply for and provides Emtriva at no medication cost if approved. Our $69.95/month service covers full advocacy. With generic emtricitabine widely available at low cost, we’ll help you and your provider determine the best path — generic FTC may be preferable for many patients.
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Emtriva:
Still $700–$900 per month even with the best discount
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Emtriva assistance.
Not sure if you qualify? Our pre-qualification check is completely free. If we can’t help, you won’t be charged.
Emtriva (emtricitabine, FTC) is a once-daily NRTI used as a component of combination antiretroviral therapy for HIV-1. It is closely related to lamivudine (3TC) but with a slightly longer intracellular half-life and greater potency in some contexts.
How Emtriva Works:
Emtricitabine is a potent NRTI that functions as a cytidine analog to block HIV replication. Once inside the cell, it is incorporated into the developing viral DNA chain by the reverse transcriptase enzyme. Because it lacks the necessary chemical group to link with the next building block, it causes premature chain termination, effectively stopping the virus from copying its genetic material.
Form and use:
Marketed as Emtriva, the standard adult dose is one 200 mg capsule taken once daily, with or without food. A liquid oral solution is also available for pediatric patients or individuals who have difficulty swallowing pills. It is important to note that Emtriva is never used as a standalone treatment and must always be combined with other antiretroviral medications.
Generic availability:
Generic emtricitabine is widely available in the United States at a much lower cost than the brand-name version. While the standalone generic exists, most patients actually receive the drug as part of a fixed-dose combination tablet, such as Biktarvy or generic Truvada. These combination therapies are generally preferred over taking Emtriva as a separate pill.
Warnings:
Emtriva carries a boxed warning regarding severe HBV exacerbations, requiring all patients to be tested for Hepatitis B before starting treatment. Potential risks include immune reconstitution syndrome and rare instances of lactic acidosis or severe liver enlargement. Additionally, using the drug without other effective antiretrovirals can lead to the development of HIV drug resistance.
Brand Emtriva costs approximately $700–$900 per 30-day supply. Generic emtricitabine is dramatically cheaper — often $20–$60/month with a coupon. Through AffordMyPrescriptions, qualifying patients receive brand Emtriva at no medication cost — our $69.95 monthly fee covers full advocacy and program management. If generic emtricitabine is appropriate for your regimen, we can help confirm that’s a cheaper path.
Most adults take FTC as part of a combination single-tablet regimen because pill burden and adherence are easier. Standalone Emtriva is occasionally used in pediatric patients (where weight-based dosing matters), in patients with specific drug interactions or kidney issues that require non-fixed-dose dosing, or in patients with renal impairment requiring dose adjustment of FTC alone
Yes. The FDA requires generics to be bioequivalent to brand. Generic emtricitabine has the same active ingredient at the same dose as Emtriva. Most insurance plans prefer generic over brand. For HIV treatment, generic FTC is widely accepted as clinically equivalent
Yes. Medicare Part D beneficiaries can typically qualify. State ADAP programs may also coordinate with Medicare for HIV-treatment patients. However, given the wide availability of generic emtricitabine, many Medicare patients can access FTC at very low cost without needing PAP.
Tell your prescriber. Emtricitabine is active against HBV — but if Emtriva is ever stopped without other anti-HBV therapy, severe acute HBV flares can occur. HBV testing is required before starting.
That’s a clinical decision between you and your HIV provider. Single-tablet regimens (Biktarvy, Genvoya, Odefsey, Descovy + INSTI) simplify dosing and improve adherence for most patients. Standalone Emtriva is now relatively uncommon outside of specific clinical scenarios
If denied, we explore alternatives — switching to generic emtricitabine (very low cost), state ADAP, the manufacturer’s copay program for commercially insured patients, or independent foundations. If we cannot find a path, you won’t be charged our service fee.
If you are struggling with the high cost of Emtriva, our team may be able to help you access assistance programs — or guide you to generic emtricitabine if it fits your situation. Check your eligibility today.
Start free by filling out a simple online form.
Our specialist will contact you for a quick welcome call.
Our team handles everything, so you can focus on your health.